Detection of extended-spectrum β-lactamase in Pseudomonas aeruginosa

Indian Journal of Pathology and Microbiology

Volumn 51, Issue 2, 2008, Pages 222-224

  Aggarwal, Ritu ^a,b   Chaudhary, Uma ^a   Bala, Kiran ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b HUDA   (India)

Author keywords

lactams; Pseudomonas aeruginosa; Third generation cephalospronis

Indexed keywords

AZLOCILLIN; CEFOPERAZONE; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LOMEFLOXACIN; NETILMICIN; OFLOXACIN; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD; BODY FLUID; CEREBROSPINAL FLUID; DISK DIFFUSION; ENZYME SYNTHESIS; HOSPITAL INFECTION; INFECTION CONTROL; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PUS; SPUTUM; SPUTUM SMEAR; TRACHEOSTOMY; URINE;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IMIPENEM; INDIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 46949099616     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.41693     Document Type: Article

References (15)

1. Shahid M, Malik A, Sheeba. Multidrug resistant Pseudomonas aeruginosa strains harbouring R-plasmids and Amp C β-lactamases isolated from hospitalized burn patients in tertiary care hospital of North India. FEMS Lett 2003;228:181-6.
2. Naas T, Phiippon L, Poirel L, Ronco E, Nordmann P. An SHV-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999;43:1281-4.
3. Mugnier P, Dubrous P, Casin I, Arlet G, Collatz E. A TEM-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996;40:2488-93.
4. Clinical laboratory standards institute. Performance standards for antimicrobial susceptibility testing. Sixteenth international supplement. CLSI document M100 - S 16, Wayne PA: 2007.
5. Colle JG, Miles RS, Wan B. Tests for the identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A, Editors. Mackie and McCartney Practical Medical Microbiology, 14th ed. Edinburg: Churchill Livingstone; 1996. p. 131-50.
6. th ed. Approved standard. NCCLS document M2-A7, Vol. 20 No. 1; Wayne PA: January 2000.
7. Jarlier V, Nicolas MH, Fourneir G. Extended spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 1998;10:867-78.
8. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum β-lactamase producing gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002;115:153-7.
9. Jacobson KL, Cohen SH, Inciardi JF, King JH, Lippert WE, Iglesias T, et al. The relationship between antecedent antibiotic use and resistance to extended spectrum cephalosporins in Group I β-lactamase producing organisms. Clin Infect Dis 1995;21:1107-13.
10. nd. Extended spectrum β-lactamases: Epidemiology, detection and treatment. Pharmacotherapy 2001;21:920-8.
11. Thomson KS, Sanders CC. Detection of extended spectrum β-lactamases in members of family Enterobacteriaceae: Comparison of the double disk and three dimensional tests. Antimicrob Agents Chemother 1992;36:1877-82.
12. Pena C, Pujol M, Ardanuy C. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended spectrum β-lactamases. Antimicrob Agents Chemother 1998;42:53-8.
13. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended spectrum β-lactamase phenotype and characterisation of isolates from Europe, the Americans and the Western Pacific region. Clin Infect Dis 2001;32:594-603.
14. Abigail S, Mathai E, Jesudason MV, John TJ. Ceftazidime resistance among Klebsiella pneumoniae in South India. Indian J Med Res 1995;102:53-5.
15. Subha A, Ananthan S. Extended spectrum β-lactamase mediated resistance to third generation cephalosporins among Klebsiella pneumoniae in Chennai. Indian J Med Microbiol 2002;20:92-5.